Title:
SOLID PERORAL CONTRACEPTIVE DRUG
Document Type and Number:
WIPO Patent Application WO2006087177
Kind Code:
B1
Abstract:
Disclosed is a solid peroral contraceptive drug containing 17a-cyanomethyI-17-ß-hydroxyestra-4,9-dien-3on (dienogest) at a daily dose that is equal to or smaller than 2.0 mg as one active component and 17a-ethinyl estradiol (ethinyl estradiol) at a daily dose of less than 0.03 mg as another active component along with one or several pharmaceutically acceptable carriers. The dienogest is proportionately released in at least two phases while the ethinyl estradiol is released at the same time as the first phase of the dienogest.
Inventors:
FRICKE SABINE (DE)
GERECKE HAGEN (DE)
LADWIG RALF (DE)
BUSKE ALEXANDER (DE)
RAETHE HARALD (DE)
GERECKE HAGEN (DE)
LADWIG RALF (DE)
BUSKE ALEXANDER (DE)
RAETHE HARALD (DE)
Application Number:
PCT/EP2006/001358
Publication Date:
October 11, 2007
Filing Date:
February 15, 2006
Export Citation:
Assignee:
BAYER SCHERING PHARMA AG (DE)
FRICKE SABINE (DE)
GERECKE HAGEN (DE)
LADWIG RALF (DE)
BUSKE ALEXANDER (DE)
RAETHE HARALD (DE)
FRICKE SABINE (DE)
GERECKE HAGEN (DE)
LADWIG RALF (DE)
BUSKE ALEXANDER (DE)
RAETHE HARALD (DE)
International Classes:
A61K9/20
Download PDF:
Previous Patent: COKE QUENCHING CAR AND METHOD FOR MEASURING THE WEIGHT OF COKE
Next Patent: METHOD AND DEVICE FOR GRANULATING PLASTICS AND/OR POLYMERS
Next Patent: METHOD AND DEVICE FOR GRANULATING PLASTICS AND/OR POLYMERS